Spain Medical Oxygen Concentrators Market

What is the Spain Medical Oxygen Concentrators Market Size?

As per the survey report on Spain medical oxygen concentrators market, the market is expected to foresee a CAGR value of 7.1% during 2026-2036, and further generate a market size of USD 501.1 million by the end of 2036. In 2025, the market size was value at USD 237.2 million revenue.

• The Spain medical oxygen concentrators market’s growth is driven by rising prevalence of respiratory diseases.
• KDMI analyst’s growth analysis foresees maintenance and operational challenges as restraint for Spain medical oxygen concentrators market.
• In the Spain medical oxygen concentrators market, form segment is playing significant role.

Spain Medical Oxygen Concentrators Market Analysis

Oxygen concentrators are a type of medical devices that separates nitrogen from the air to provide 95% of pure oxygen to patient. Doctor prescribes such medical devices for individuals suffering from asthma, lung cancer, sleep apnea, bronchitis, and other diseases. The Spain medical oxygen concentrators market growth is driven by rising number of patients suffering from chronic respiratory conditions and enabling them to maintain adequate oxygen saturation levels. According to clinic Barcelona study, in the country, nearly 5.7% of children under the age of 14 have asthma and 11.4% have allergies, mainly allergic rhinitis. The data indicates that there are approximately 795,000 children with some type of allergy and 397,000 with asthma. Moreover, growing shift toward greener technologies that supports sustainability initiatives are encouraging innovations integration in medical device sector, thereby boosting market growth.

Spain Medical Oxygen Concentrators Market Growth Drivers and Restraints

Growth Drivers

• Rising prevalence of respiratory diseases – The increasing prevalence of respiratory diseases is a major factor driving the Spain medical oxygen concentrators market. Chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and sleep-related breathing disorders are becoming more common across the country. According to NIH report, over 14% of country’s population is affected from chronic respiratory diseases, being the third leading cause of death in 2022. Respiratory diseases accounted for nearly 2 million emergency care visits in 2022. The respiratory diseases are caused due to smoking habits, environmental pollution, and occupation exposure to harmful substances. As the burden of respiratory illness continues to rise, demand for oxygen concentrators also accelerates across Spain.
• Growing aging population – Spain’s elderly population is significantly contributing to the expansion of medical oxygen concentrators market, as older adults are more vulnerable to chronic respiratory conditions. According to NIH report, the percentage of older adults is at 20%, which is projected to rise to 36.8% in 2050. Additionally, chronic diseases affect more than half of Spanish population aged 40 years and above . Therefore, there is increasing need for continuous oxygen therapy among the aging population. Medical oxygen concentrators provide a practical and cost-effective solutions for managing chronic conditions, particularly in homecare environments.
• Rising spending on medical devices – Increasing spending on medical devices is emerging as an important growth driver for the Spain medical oxygen concentrators market. According to ITA, in 2021, the public health budget was USD 96.7 billion, accounting for approximately 6.6% of GDP. The Ministry of Health, Consumer Affairs, and Socia Services recorded total expenditure of USD 136.5 billion, or 9.3% of the country’s GDP . Therefore, growing healthcare expenditure is creating opportunities for the increased deployment of medical oxygen concentrators across Spain.

Restraints

• Maintenance and operational challenges – Medical oxygen concentrators often require maintenance, filter replacement, and periodic servicing to ensure optimal performance. Equipment downtime, maintenance expenses, and the need for technical support further creates challenges for healthcare providers and homecare users, which limits overall market growth.
• Reimbursement constraints – Another key challenge is variations in reimbursement policies and healthcare funding, which can affect patient access to oxygen concentrators. Budget limitations across healthcare system delays deployment, thereby impacting market negatively.

Spain Medical Oxygen Concentrators Market Segmentation

Our experts at KD Market Insights have segmented the Spain medical oxygen concentrators market research report as:

Spain Medical Oxygen Concentrators Market Competitive Landscape

Some of the significant participants who top the Spain medical oxygen concentrators market growth:

• Philips Healthcare (Koninklijke Philips N.V.)
• Invacare Corporation
• Inogen, Inc.
• Drive DeVilbiss Healthcare
• CAIRE Inc. (now part of Inogen)
• AirSep (a division of Chart Industries)
• Chart Industries, Inc.
• ResMed Inc.
• Fisher & Paykel Healthcare Limited
• OXLife (Oxygen Concentrator Manufacturers)
• Nidek Medical Products
• Devilbiss Healthcare (Drive DeVilbiss)
• Precision Medical, Inc.
• EverFlo (Philips brand)
• Beijing Pride Medical Technology Co., Ltd.